JG
Jason Gerberry BofA Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
20
Avg Return
Past Year
Past Year
14%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
71.4%
Neutral
19%
Negative
9.5%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $83 |
19%
upside
| 1 | +14% |
0
%
| 23 Sep ‘25 19 days ago |
|
|
|
Neutral
Maintained
| $32 |
35%
upside
| 1 | – |
–
| 26 Aug ‘25 1 month ago |
|
|
|
Buy
Maintained
| $30 |
76%
upside
| 3 | -8% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $49 |
210%
upside
| 1 | +18% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $176 |
45%
upside
| 2 | -0.96% |
0
%
| 5 Aug ‘25 2 months ago |
|
|
|
Underperform
Downgraded
| $1 |
67%
downside
| 1 | -352% |
0
%
| 30 Jun ‘25 3 months ago |
|
|
|
Buy
Maintained
| $23 |
1%
downside
| 1 | +55% |
0
%
| 11 Jun ‘25 4 months ago |
|
|
|
Neutral
Maintained
| $46 |
21%
upside
| 3 | +37% |
0
%
| 5 Jun ‘25 4 months ago |
|
|
|
Buy
Maintained
| $22 |
10%
upside
| 2 | +12% |
0
%
| 8 May ‘25 5 months ago |
|
|
|
Buy
Maintained
| $137 |
214%
upside
| 1 | +16% |
0
%
| 1 Apr ‘25 6 months ago |
|
|
|
Underperform
Maintained
| $10 |
3%
upside
| 1 | -2.2% |
0
%
| 28 Feb ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $30 |
47%
upside
| 1 | -11% |
0
%
| 9 Jan ‘25 9 months ago |
|
|
|
Neutral
Downgraded
| $10 |
101%
upside
| 1 | – |
–
| 15 Nov ‘24 11 months ago |
|
|
|
Buy
Maintained
| $100 |
15%
upside
| 2 | -3.3% |
0
%
| 6 Nov ‘24 11 months ago |
|